Big Board

Keyword
Content Ideas
Result Content Idea Research
Result Content Idea Research
1 Something old, something new combine for effective vaccine against parasitic skin disease
2 Global Leishmaniasis Treatment Market Is Expected to Reach USD 223.88 million by 2027 : Fior Markets
3 Leishmania infection and blood sources analysis in Phlebotomus chinensis (Diptera: Psychodidae) along extension region of the loess plateau, China
4 Leishmaniasis Treatment Market 2020: Size, share, Global Industry Trends, Growth Drivers, Business Opportunities and Demand Forecast to 2027
5 Flow cytometry in neglected tropical diseases – a focus on leishmaniasis
6 Keratitis occurring in patients treated with miltefosine for post-kala-azar dermal leishmaniasis
7 Insecticide spraying and awareness campaign on the Leishmaniasis disease in Idlib countryside
8 Emerging parasitic disease mimics the symptoms of visceral leishmaniasis in people
9 CBD For Leishmaniasis: What Does The Science Say?
10 Cases of Leishmaniasis Increasing in the United States, Vaccine in Development
11 Global Leishmaniasis Treatment Market 2020 Industry Status
12 Victory Square Technologies Portfolio Company Acquires Brazilian Manufacturing & Laboratory Facility to Increase Production of its Covid-19 Testing Products by an additional 4,000,000 Units in Bra
13 Call For Inorganic Expansion To Record A CAGR Of 3.3% In The Cutaneous And Systemic Leishmaniasis Market Between 2028
14 European bats discovered as hosts for leishmaniasis infection
15 Cutaneous Leishmaniasis Drugs Market 2020 Size, Future Demand, Global Research, Top Leading player, Emerging Trends, Region by Forecast to 2027
16 Emerging Leishmania-Like Infection Found in Brazil
17 Leishmaniasis Treatment Market | Global Industry Analysis, Segments, Top Key Players, Drivers and Trends to 2026
18 Global Leishmaniasis Treatment Market 2020 Report Reviews on Leading Competitors, Growth Trends, Future Prospects and Business Revenue Forecast to 2027
19 Study uncovers cause of aggressive leishmaniasis strain
20 Leishmania donovani Growth Inhibitors from Pathogen Box Compounds of M | DDDT
21 Abused Żejtun Dogs Being Treated At Animal Shelter, Owner To Be Charged In Court
22 Leishmaniasis
23 A study investigating genetic mechanisms underlying resistance to leishmaniasis
24 Study Uncovers Genetic Factors Behind Leishmaniasis Outcomes
25 Predicting treatment outcome for leishmaniasis | Penn Today
26 M2-like, dermal macrophages are maintained via IL-4/CCL24–mediated cooperative interaction with eosinophils in cutaneous leishmaniasis
27 Hygienic housing key to eliminating visceral leishmaniasis
28 Leishmaniasis Treatment Market To Reach USD 224.67 Million by 2027
29 As 'Flesh-Eating' Leishmania Come Closer, a Vaccine Against Them Does, Too
30 Case of Cutaneous Leishmaniasis reported in NEJM
31 Leishmaniasis in Kenya: Dozens of new cases reported
32 Strenuous efforts to curb “leishmaniasis” northern Syria
33 Leishmania virulence strategy unveiled
34 Expanding research capacity into neglected tropical diseases
35 Opinion: 3 ways to support health care workers and strong health systems
36 Natural compound 2HF treats leishmaniasis infections, study finds
37 Get Your Dog Vaccinated Against Leishmaniasis If You Live In Spain
38 Leishmania: A potential threat for immuno-compromised individuals
39 Host Expression Provides Treatment Response Clues in Cutaneous Leishmaniasis
40 Leishmaniasis Treatment Market To Reach USD 206.5 Million by 2026 | Reports And Data
41 Leishmaniasis needs more attention: it causes skin lesions, and can kill
42 How sand fly mating habits are helping tackle tropical disease in £2.5 million project
43 Study identifies virulence factors of Leishmania
44 New tropical disease detected in Brazil defies treatment
45 PLOS Papers on Extraction-Free SARS-CoV-2 Detection, Kaposi's Sarcoma, Leishmania Genetics
46 Field test for dog Leishmania exposure evaluated
47 New Research Shows How Flesh-Eating Leishmania Parasites Hide in Our Bodies to Fight Future Infections
48 Leishmaniasis spread in the Middle East during war and conflict
49 Sugar withdrawal—killing the leishmania parasite
50 Evaluation of the Anti-Leishmanial Effect of Recombinant Clostridium & | IDR
51 Investigators Use Innovative Approach to Explore New Treatment Options for Leishmaniasis
52 Study sheds light on the metabolism of Leishmania parasite
53 Rare Parasitic Infection 'Leishmaniasis' Rising in the US
54 Kenya leishmaniasis update: Two dozen cases reported in past week
55 How does the body respond to diffuse cutaneous leishmaniasis?
56 Mobile clinics to restore medical reality in rebel-held northern Syria
57 Can we treat leishmaniasis with tiny magnets?
58 Cutaneous leishmaniasis emerging among refugees in Lebanon
59 Dormant leishmaniasis parasites: threat to control
60 A gutsy survival of Leishmania in multiple sand fly species
61 Viral communications hacking boosts Leishmania infections
62 Novartis and DNDi to jointly develop a new oral drug to treat visceral leishmaniasis
63 Kala azar (visceral leishmaniasis) | MSF UK | Médecins Sans Frontières UK
64 How visceral leishmaniasis spread through central-Southern Brazil
65 Discovery of molecular mechanism behind spread of leishmania infection
66 Kenya: Four Leishmaniasis deaths reported in Kitui County, Kenya
67 Leishmania and its Survival Mechanisms
68 Novartis, DNDi to jointly develop LXE408 for visceral leishmaniasis
69 Viruses exacerbate disease caused by Leishmania parasite
70 Leishmaniasis causes skin lesions, and is often lethal
71 Genetically Engineered Ascorbic acid-deficient Live Mutants of Leishmania donovani induce long lasting Protective Immunity against Visceral Leishmaniasis
72 Attenuated Leishmania induce pro-inflammatory mediators and influence leishmanicidal activity by p38 MAPK dependent phagosome maturation in Leishmania donovani co-infected macrophages
73 A new species of Leishmania?
74 Novartis to develop new oral drug for visceral leishmaniasis
75 WHO provides support for treatment of leishmaniasis in Libya
76 Detection and Differentiation of Leishmania spp. in Clinical Specimens by Use of a SYBR Green-Based Real-Time PCR Assay
77 Topical cream found as less-toxic therapy to treat cutaneous leishmaniasis
78 Nanodrug tames leishmaniasis and other parasitic diseases
79 Advancement in drug therapies may provide new treatment for Cutaneous leishmaniasis: Syrian conflict has led to an increased number of cases, spread to neighboring countries
80 Leishmaniasis spreads rapidly in Deir Ezzor infecting hundreds of children
81 Leishmaniasis strain in Iraq outbreak identified
82 Pernicious Parasite Strikes Explorers of ‘Lost City’
83 How the leishmania parasite sabotages the immune response
84 Treatment for canine leishmaniasis exists in Brazilian vaccine
85 Clinical trials on for an advanced oral drug for kala-azar
86 Identification of Leishmania by Matrix-Assisted Laser Desorption Ionization–Time of Flight (MALDI-TOF) Mass Spectrometry Using a Free Web-Based Application and a Dedicated Mass-Spectral Library
87 Hit-to-lead in neglected diseases – it's a numbers game
88 WHO | WHO addressing leishmaniasis in high-risk areas of the Syrian Arab Republic
89 Quantitative proteomics reveals a broad‐spectrum antiviral property of ivermectin, benefiting for COVID‐19 treatment
90 Asymptomatic visceral leishmaniasis prevalent in US soldiers deployed to Iraq
91 Leishmaniasis: Genes key to identifying drug resistant parasites in Brazil
92 Post-elimination surveillance of visceral leishmaniasis in South-Asia: the need for molecular surveillance
93 Skin plays significant role in spread of leishmaniasis
94 Sweet success of parasite survival could also be its downfall
95 WHO provides anti-Leishmania medicines to Libya
96 Traditional Medicine for Leishmaniasis
97 Leishmaniasis breaks the equilibrium
98 Infectious parasite shows signs of sexual reproduction
99 Once thought to be asexual, single-celled parasites caught in the act
100 Accurate Serodetection of Asymptomatic Leishmania donovani Infection by Use of Defined Antigens